HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health, Beauty And Wellness News: Launches, Petition, Recalls, Ad Campaign, 'Irreparably Defective' SOP

This article was originally published in The Rose Sheet

Executive Summary

Earth Mama offers mineral sunscreens; AHPA petitions for pullulan, adds Sustainability Subcommittee; POM Wonderful campaigns with 'Worry Monsters'; Herbalife perks iced protein; 'Disposal/Destruction of Irreparably Defective Articles' SOP draft ready; King Bio-linked homeopathic recalls expand; and Forager recalls protein shakes.

You may also be interested in...



Health, Beauty And Wellness News: Herbalife Q3, NPA On Part 111 Trends, AHPA's Zimmerman Awarded

AHPA's Zimmerman receives AHG's 'Best Contribution' award; NPA notes Part 111 violations common and emerging; saw palmetto BAPP update notes adulteration developments; China results lead Herbalife sales jump; and China deal delay moves GNC Q3 report date.

Health, Beauty And Wellness Regulatory News: Warnings, Alerts, Recalls

Fourth recall of homeopathics linked to contaminated water; FDA posts alerts about Texas coop's products; and warnings note drug claims, GMP problems, same-site drug production.

Court Upholds FTC Order Against POM, But Scrutinizes Clinical Trial Requirement

The U.S. Court of Appeals for the District of Columbia Circuit on Jan. 30 issued a ruling largely upholding the FTC’s 2012 order against POM, but said the agency’s argument fails “scrutiny insofar as it categorically requires two RCTs for all disease-related claims.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122076

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel